- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 33.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 34.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 36.17M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $25.75M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $2.44M |
| Capex | Q1 2026 · Mar 31, 2026 | $351K |
| Capex | Q1 2026 · Mar 31, 2025 | $27K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $88.98M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $52.48M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $120.45M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $64.05M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $196.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $169.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $125.76M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $87.84M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $112.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $89.77M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $257.58M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $230.42M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $411.19M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $351.86M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $454.31M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $400.23M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.47 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.52 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.07 |
| Net Income | Q1 2026 · Mar 31, 2026 | $51.3M |
| Net Income | Q1 2026 · Mar 31, 2025 | $36.16M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $69.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $49.9M |
| Revenue | Q1 2026 · Mar 31, 2026 | $73.29M |
| Revenue | Q1 2026 · Mar 31, 2025 | $48.17M |